VKH
AMRI

Virtu KCG Holdings’s Albany Molecular Research Inc AMRI Stock Holding History

Virtu KCG Holdings’s Portfolio AMRI Stock Details AMRI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		$293K Buy
+13,517
New +$245K 0.01% 1702
2014
Q2 		– Sell
-12,863
Closed -$239K – 4279
2014
Q1 		$239K Buy
12,863
+841
+7% +$11.6K ﹤0.01% 2788
2013
Q4 		$121K Buy
+12,022
New +$145K ﹤0.01% 3384

Other funds holding AMRI

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACM
American Capital Management New York $1.86B AUM 20.23% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
WIC
Water Island Capital New York $896M AUM 107.59% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
CCM
Chicago Capital Management Chicago, Illinois $112M AUM 76.54% 1-Year Est. Return
EWM
Evercore Wealth Management New York $6.36B AUM 20.35% 1-Year Est. Return

Virtu KCG Holdings's AMRI Position: Q2 2017 in Review

Virtu KCG Holdings opened a new position in Albany Molecular Research Inc (AMRI) in Q2 2017: 13,517 shares worth $293K. The stake represents 0.01% of the portfolio and ranks #1702 among its holdings. This is a return to the name: Virtu KCG Holdings previously reported a position in AMRI as recently as Q1 2014.

Virtu KCG Holdings first reported a position in AMRI in Q4 2013 and has held it in 3 quarters since. 136 funds tracked by Wall St. Rank hold AMRI as of Q2 2017.

  • Virtu KCG Holdings held 13,517 shares of Albany Molecular Research Inc worth $293K as of Q2 2017.
  • Albany Molecular Research Inc was a new Virtu KCG Holdings position in Q2 2017.
  • Albany Molecular Research Inc made up 0.01% of Virtu KCG Holdings's portfolio in Q2 2017, its #1702 holding.
  • Virtu KCG Holdings first reported a position in Albany Molecular Research Inc in Q4 2013 and has held it in 3 quarters since.
  • 136 funds tracked by Wall St. Rank held Albany Molecular Research Inc as of Q2 2017.

Based on Virtu KCG Holdings's 13F filing for Q2 2017, filed 11 Aug 2017.